Hudson Therapeutics, Inc.
  • Home
  • About US
  • PIPELINE
  • INFLAMMASOME
  • NANOBODY
  • News
  • More
    • Home
    • About US
    • PIPELINE
    • INFLAMMASOME
    • NANOBODY
    • News
Hudson Therapeutics, Inc.
  • Home
  • About US
  • PIPELINE
  • INFLAMMASOME
  • NANOBODY
  • News

Hudson Therapeutics - Shaperon USA

Hudson Therapeutics - Shaperon USAHudson Therapeutics - Shaperon USAHudson Therapeutics - Shaperon USA

Healing through Innovation

Hudson Therapeutics - Shaperon USA

Hudson Therapeutics - Shaperon USAHudson Therapeutics - Shaperon USAHudson Therapeutics - Shaperon USA

Healing through Innovation

At Hudson Therapeutics, Inc., we are on a mission to enhance and restore patients' lives by advancing novel compounds into innovative drugs through an extensive global clinical development process. Our commitment to innovation, strategic partnerships, and patient-centricity drives every aspect of our work.  

Our Origins

Strategic Partnerships

Strategic Partnerships

Hudson Therapeutics, Inc. is a subsidiary of Shaperon, Inc., which is the listed on Kosdaq in South Korea. With a team of experienced experts and a relentless commitment to excellence, we have taken the legacy of Shaperon, Inc. to new heights.  

Strategic Partnerships

Strategic Partnerships

Strategic Partnerships

Business Development (BD) experts at Hudson Therapeutics, Inc. play a crucial role in our success. They work to license out assets from Shaperon, Inc. to global pharmaceutical leaders. Our partners trust us to deliver innovation that transforms lives.  

Clinical Excellence

Strategic Partnerships

Clinical Excellence

Our clinical experts at Hudson Theapeutics, Inc. manage global clinical trials for these assets after obtaining Investigational New Drug (IND) approvals. We're committed to ensuring that these potential breakthroughs reach patients around the world.  

#

PIPELINE

#

INFLAMMASOME

#

NANOBODY

 © 2023 Hudson Therapeutics, Inc.

The information presented on this website is derived from the official website of our parent company, Shaperon, Inc. This site is designed exclusively to showcase Hudson Therapeutics, Inc. to potential investors and partners. Please note that we are not responsible for any misuse of the content outside its intended purpose.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept